Artigo Revisado por pares

Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa

2008; Elsevier BV; Volume: 26; Issue: 22 Linguagem: Inglês

10.1016/j.vaccine.2008.02.071

ISSN

1873-2518

Autores

Walter Jaoko, Frederick N. Nakwagala, Omu Anzala, Gloria Omosa Manyonyi, Josephine Birungi, Annet Nanvubya, Bashir Farah, Kirana Bhatt, Hilda Ogutu, Sabina Wakasiaka, Lucy Matu, Wambui Waruingi, Jane Odada, Micah Oyaro, Jackton Indangasi, Jeckonia Ndinya-Achola, Carol Konde, Emmanuel Mugisha, Patricia Fast, Claudia Schmidt, Jill Gilmour, Tony Tarragona, Carol Smith, Burc Barin, Len Dally, Bruce Johnson, Andrew Muluubya, Leslie Nielsen, Peter Hayes, Mark Boaz, Peter J. Hughes, Tomáš Hanke, Andrew J. McMichael, Job J. Bwayo, Pontiano Kaleebu,

Tópico(s)

Herpesvirus Infections and Treatments

Referência(s)
Altmetric
PlumX